LATEST ANNOUNCEMENT

Seer Medical receives FDA 510(K) clearance for ambulatory epilepsy monitoring technology

Melbourne, Australia, September 27, 2022 — Clinical monitoring company Seer Medical has obtained U.S. Food and Drug Administration (FDA) approval of Seer Home™ for the diagnosis of epilepsy via multi-day video-EEG-ECG monitoring.Launched in